Arcam receives order from DiSanto Technology for two Arcam Q10 systems

Jun 24 2014

Arcam (STO:ARCM), listed on NASDAQ OMX, has received an order for two Arcam Q10 systems from the strategic partner DiSanto Technology Inc. in the US. The systems will be used for manufacturing of orthopedic implants.

In spring 2013 Arcam and Disanto Technology Inc. entered into a strategic cooperation in order to make a joint development of customers for contract manufacturing of advanced orthopedics implants based on Arcam´s EBM technology. In connection with the cooperation DiSanto bought two EBM systems. With this new order DiSanto increases its EBM based production.

"The cooperation with DiSanto is developing very well and with this new order DiSanto increases its manufacturing capacity to meet the demand on EBM manufactured implants", says Magnus René, CEO of Arcam.